Equites Radar

ADUS · Addus HomeCare Corporation

Medical Care FacilitiesUnited StatesAnalyst view: Buy

$117.84

-0.57% last session

End-of-day data · close of 2026-09-11

Bullish4 bullish · 1 bearish technical signals
Consensus: Buy (1.57 from 13 analysts)
To mean target: +13.6%

Market cap

$2B

Enterprise value

$2B

Trailing P/E

20.8

Forward P/E

15.8

Dividend yield

Beta

0.86

Avg volume

0M

Employees

6K

Daily Change %

-0.57%

5 Days Change

0.40%

10 Days Change

3.98%

30 Days Change

2.00%

60 Days Change

10.18%

Month to Day Change

4.09%

Year to Day Change

11.03%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.57
Covering analysts13
Mean price target$134.69
Low price target$96.00
Upside to mean target+13.6%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)52.2
50-day MA$115.39
200-day MA$105.79
Price vs 50-day MA+2.1%
Price vs 200-day MA+11.4%
MACD histogram-0.32
Volume vs 3-month avg0.3×
52w low $88.4952w high $122.75

Analyst sentiment over time — ADUS

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-05

Latest call per bank · past 12 months

RBC Capital

Outperform

$134

+13.1% vs price
▲ raised from $130Maintains · 2026-08-05

Barclays

Underweight

$96.00

-19.0% vs price
▲ raised from $92.00Maintains · 2026-07-09

Recent rating actions

DateFirmActionRatingPrice target
2026-08-05RBC CapitalMaintainsOutperform$130 $134
2026-07-09BarclaysMaintainsUnderweight$92.00 $96.00
2026-05-18CitizensReiteratesMarket Outperform$142
2026-05-15BarclaysMaintainsUnderweight$102 $92.00
2026-05-06CitizensMaintainsMarket Outperform$150 $142
2026-03-25BarclaysMaintainsUnderweight$112 $102
2026-02-25Stephens & Co.MaintainsOverweight$140 $135
2026-02-24BarclaysMaintainsUnderweight$117 $112

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 52 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 2.1% above the 50-day MA ($115.39).
  • Price vs 200-day MA: Trading 11.4% above the 200-day MA ($105.79).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.32) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($122.75).

ADUS Price Chart

Loading chart for ADUS

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$62.76
Net Debt / EBITDA0.1
WACC10.0%
Revenue growth8.00%
Earnings growth24.00%

About Addus HomeCare Corporation

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

More in Medical Care Facilities

Screen ADUS against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.